Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Relay Therapeutics (NASDAQ:RLAY) through any online brokerage.
Other companies in Relay Therapeutics’s space includes: Precigen Inc (NASDAQ:PGEN), Immatics NV (NASDAQ:IMTX), AnaptysBio Inc (NASDAQ:ANAB), Agios Pharmaceuticals Inc (NASDAQ:AGIO) and Tyra Biosciences Inc (NASDAQ:TYRA).
Relay Therapeutics has a consensus price target of $16.47.
The stock price for Relay Therapeutics (NASDAQ: RLAY) is $8.87 last updated February 13, 2026 at 4:03 PM EST.
There are no upcoming dividends for Relay Therapeutics.
Relay Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Relay Therapeutics.
Relay Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.